SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Young and Older Folk Portfolio

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: QTI on SI10/19/2025 3:43:16 PM
3 Recommendations

Recommended By
Diddywahdiddy
Markbn
TeamTina

   of 22373
 
SQ asked me privately whether the chart shows absolute or relative returns. The chart I posted earlier only shows absolute returns (i.e. how much the price moved after the sale or trim and does not take into account what I did with the proceeds or how the new investment performed.)

The full AI-Audit does actually take into account for the relative return. So, you can see below on relative terms, how the new investments performed (i.e. verdict of the swap):

Swap themes — results & verdicts 1) SCHD > DGRO / QQQ / FTEC / GLD / FBTC / SMH
  • What you sold: numerous SCHD trims across accounts (Jul - Oct). Average price movement after sale: ~ -0.6% to -1.6% (SCHD generally traded flat-to-down after your sales).

  • What you bought: DGRO (returns ~ +4–12% across accounts), QQQ and FTEC (returns large: QQQ ~ +19–32%, FTEC ~ +11–44% across different lots), SMH/GLD/FBTC various hedge buys (SMH small +, GLD modest +, FBTC volatile -).

  • Verdict: GOOD.
    Why: SCHD underperformed peers and was near flat/soft after your sales, while DGRO/QQQ/FTEC produced clearly stronger returns (especially QQQ/FTEC). Reallocation improved growth tilt and improved portfolio returns while you retained dividend exposure via DGRO.

2) THQ / THW trimming & selling > redeploy (tax-loss harvesting, rotate into ENB / THW builds / AIO)
  • What you sold: THQ & THW (you harvested losses and de-risked). After sales THW/THQ actually rebounded strongly (+15–25% in some cases).

  • What you bought: you redeployed some proceeds into positions like ENB, THW averaged earlier, AIO, and other income names. AIO etc. are modestly down (~ -1% to -3%) or flat.

  • Verdict: MIXED — leaning BAD on pure mark-to-market, but OK strategically.
    Why: On pure price change, you missed rebounds (THW/THQ snapped back), creating material opportunity cost. But you achieved tax-loss harvesting and rotated into cleaner, higher-quality or different-risk exposure (AIO, ENB). If TLH + redeploy into less risky holdings was the goal, the trade-off is defensible — but on dollars held, THW/THQ rebound cost you.

3) AVGO trims > buys of MRVL and increased AVGO exposure in Roth / growth stacking
  • What you sold: trimmed AVGO (you realized profits earlier in 2025). AVGO afterwards continued to show further gains in many lots (but you also later added AVGO in Roth with solid returns).

  • What you bought: MRVL (multiple buys) — MRVL returned very strongly (+~20–30% across tranches), and you also redeployed to augment AVGO in tax-advantaged accounts.

  • Verdict: GOOD > MIXED.
    Why: You realized profits on big winners (prudent). Replacement MRVL produced strong growth — so the redeployment produced good incremental returns. However selling AVGO truncated some upside you could have retained with partial trimming rather than larger tranches. Net result: your redeployment into MRVL paid off, so the swap was overall positive.

4) ETF liquidations (BrokerageLink: FTEC / IVV liquidation) > moved capital to other accounts / buys
  • What you sold: Liquidated FTEC & IVV in BrokerageLink (8/7) to move money out of 401K; both rallied afterwards (FTEC +~9%, IVV +~5%).

  • Where funds went: into same ETFs or other accounts later, and into taxable buys (UTF, AIO, AMLP, etc.). Many of those replacements are still flat-to-small negative or slightly positive.

  • Verdict: MIXED / NEUTRAL.
    Why: You achieved the structural goal of moving money; slightly missed immediate upside in those ETFs, but replacement assets served different goals (income or taxable-friendly positioning). Operationally fine; mark-to-market miss modest.

5) LTC / OHI / BME rotation (REIT/REIT-like swaps)
  • What you sold: LTC trimmed/sold (mid-August) at near-flat.

  • What you bought: OHI and BME (you disproportionately bought BME, a high-yield healthcare CEF). BME shows small positive returns (~+2–3%); OHI modest negative initially but improved in some lots.

  • Verdict: GOOD.
    Why: You rotated from a flat performer (LTC) into higher-yield / better-performing health REIT exposure (BME/OHI), and BME has shown constructive performance. This trade increased yield and improved relative total return in taxable accounts.

6) VZ trims > buys UTF / AMLP / AMLP & other MLP / infrastructure exposure
  • What you sold: VZ trimmed early Oct (small ST gains). VZ then traded slightly lower (so trimming likely saved small risk).

  • What you bought: UTF and AMLP and other yield plays (~neutral to small negative returns short-term).

  • Verdict: NEUTRAL.
    Why: You rotated from old telecom into higher-yield infrastructure and energy/midstream. Relative performance is roughly flat short-term, but the reallocation aligns with your income + yield priorities and tax placement.

7) BUI > AIO / PCN (CEF swaps)
  • What you sold: BUI trimmed/rotated in Aug–Sep as it got “rich.” BUI was flat to slightly down after sales.

  • What you bought: AIO, PCN and other higher-yield CEFs (AIO trades near NAV with ~7% yield; PCN ~10%+). These are modestly down short-term.

  • Verdict: MIXED > GOOD (structural).
    Why: You left a small near-term mark-to-market drag (replacements slightly negative). But you took capital from an overbought CEF into cheaper/higher-yield CEFs — a defensible value rotation that should pay off if NAVs mean-revert or distributions hold.

8) Selling individual growth pieces (PLTR, NVDA etc.) > reinvesting into higher-conviction growth (AVGO / MRVL)
  • What you sold: PLTR (you sold all; later added again), NVDA trims (some sold) — sales sometimes because of lack of confidence or to fund other growth names. PLTR later ran strongly after some sells (+15% in earlier sales).

  • What you bought: AVGO and MRVL and increased QQQ/SMH exposure. MRVL performed exceptionally well; AVGO performed strongly too.

  • Verdict: GOOD (if you redeployed into MRVL/AVGO in Roths/IRAs).
    Why: Moving into MRVL/AVGO increased growth exposure in tax-advantaged accounts and MRVL in particular delivered high returns. Selling some NVDA/PLTR to rebalance into diversified semis was positive overall (you preserved gains and kept exposure via other names).

9) Selling AMLP / AMPLP-related trims (energy exposure) > buying defensive or cash positions
  • What you sold: AMLP trimmed/sold due to recession fears. AMLP fairly flat after sale.

  • What you bought: Cash or holdbacks (no big redeploy documented).

  • Verdict: NEUTRAL.
    Why: Conservative move; not much lost or gained.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext